Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Der Pathologe

Showing results (411-420 of 3,441) with videos related to

Pageof 345
Sort By:
Der Pathologe|September 30, 2008
[WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas]S Feiden, W Feiden
Der Pathologe|September 30, 2008
[Cartilage tumors of the skeleton]G Jundt, D Baumhoer
Der Pathologe|September 23, 2008
[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]E Noetzel, J Veeck, F Horn, et al.
Der Pathologe|September 23, 2008
[Mammography screening. Concept, quality assurance and interdisciplinary cooperation]S H Heywang-Köbrunner, J Nährig, A Hacker
Der Pathologe|September 24, 2008
[Meningiomas: multiparametric approach for risk stratification and grading]K Yoo-Jin, Y Kim, N Bochem, et al.
Der Pathologe|September 24, 2008
Immunophenotyping without antibodies. New perspectives for lymphoma characterizationM Tinguely, A Hofmann, D Bausch-Fluck, et al.
Der Pathologe|September 24, 2008
[Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Implications for pathology]C Viertler, K Zatloukal
Der Pathologe|September 24, 2008
[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation]J Veeck, E Breuer, M Rose, et al.
Der Pathologe|September 24, 2008
[Molecular targets for colon cancer. VEGF, EGFR - and what else?]C Röcken
Der Pathologe|September 28, 2007
[Epithelioid and hyperpigmented melanocytic tumors. An overview]H Kutzner, L Schärer, L Requena
Pageof 345

Showing results (411-420 of 3,441) with videos related to

Sort By:
Pageof 345
Der Pathologe|September 30, 2008
[WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas]S Feiden, W Feiden
Der Pathologe|September 30, 2008
[Cartilage tumors of the skeleton]G Jundt, D Baumhoer
Der Pathologe|September 23, 2008
[Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]E Noetzel, J Veeck, F Horn, et al.
Der Pathologe|September 23, 2008
[Mammography screening. Concept, quality assurance and interdisciplinary cooperation]S H Heywang-Köbrunner, J Nährig, A Hacker
Der Pathologe|September 24, 2008
[Meningiomas: multiparametric approach for risk stratification and grading]K Yoo-Jin, Y Kim, N Bochem, et al.
Der Pathologe|September 24, 2008
Immunophenotyping without antibodies. New perspectives for lymphoma characterizationM Tinguely, A Hofmann, D Bausch-Fluck, et al.
Der Pathologe|September 24, 2008
[Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Implications for pathology]C Viertler, K Zatloukal
Der Pathologe|September 24, 2008
[Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation]J Veeck, E Breuer, M Rose, et al.
Der Pathologe|September 24, 2008
[Molecular targets for colon cancer. VEGF, EGFR - and what else?]C Röcken
Der Pathologe|September 28, 2007
[Epithelioid and hyperpigmented melanocytic tumors. An overview]H Kutzner, L Schärer, L Requena
Pageof 345